{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:58:03Z","timestamp":1790506683848,"version":"4.1.0"},"reference-count":45,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Parasitology"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alveolar echinococcosis is a neglected parasitic zoonosis caused by <jats:italic>Echinococcus multilocularis<\/jats:italic>. The pharmacological treatment is based on albendazole (ABZ). However, the low water solubility of the drug produces a limited dissolution rate, with the consequent failure in the treatment of the disease. Solid dispersions are a successful pharmacotechnical strategy to improve the dissolution profile of poorly water-soluble drugs. The aim of this work was to determine the <jats:italic>in vivo<\/jats:italic> efficacy of ABZ solid dispersions using poloxamer 407 as a carrier (ABZ:P407 solid dispersions (SDs)) in the murine intraperitoneal infection model for secondary alveolar echinococcosis. In the chemoprophylactic efficacy study, the ABZ suspension, the ABZ:P407 SDs and the physical mixture of ABZ and poloxamer 407 showed a tendency to decrease the development of murine cysts, causing damage to the germinal layer. In the clinical efficacy study, the ABZ:P407 SDs produced a significant decrease in the weight of murine cysts. In addition, the SDs produced extensive damage to the germinal layer. The increase in the efficacy of ABZ could be due to the improvement of water solubility and wettability of the drug due to the surfactant nature of poloxamer 407. In conclusion, this study is the basis for further research. This pharmacotechnical strategy might in the future offer novel treatment alternatives for human alveolar echinococcosis.<\/jats:p>","DOI":"10.1017\/s0031182020000670","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T11:24:54Z","timestamp":1587986694000},"page":"1026-1031","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":11,"title":["Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug"],"prefix":"10.1017","volume":"147","author":[{"given":"Julia","family":"Fabbri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Eugenia","family":"Pensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Mar\u00eda","family":"Albani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes Milagros","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Simonazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Daniel","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-8721","authenticated-orcid":false,"given":"Mar\u00eda Celina","family":"Elissondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"S0031182020000670_ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20078"},{"key":"S0031182020000670_ref37","volume-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2005"},{"key":"S0031182020000670_ref18","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.107-135.2004"},{"key":"S0031182020000670_ref14","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2019-0007"},{"key":"S0031182020000670_ref39","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2018-0037"},{"key":"S0031182020000670_ref32","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12834"},{"key":"S0031182020000670_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-012-3125-1"},{"key":"S0031182020000670_ref5","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2014070"},{"key":"S0031182020000670_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2004.08.009"},{"key":"S0031182020000670_ref45","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00075-18"},{"key":"S0031182020000670_ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-008-0980-x"},{"key":"S0031182020000670_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(02)00027-X"},{"key":"S0031182020000670_ref8","first-page":"85","article-title":"Development of a cyclodextrin-based flubendazole formulation to control secondary echinococcosis: pharmacokinetics, hydatid cyst morphology and efficacy in mice","volume":"29","author":"Ceballos","year":"2006","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"S0031182020000670_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2009.11.001"},{"key":"S0031182020000670_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00608219"},{"key":"S0031182020000670_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00009-3"},{"key":"S0031182020000670_ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000316827"},{"key":"S0031182020000670_ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-012-2954-2"},{"key":"S0031182020000670_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2004.05.001"},{"key":"S0031182020000670_ref40","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-204-5_17"},{"key":"S0031182020000670_ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-12-1"},{"key":"S0031182020000670_ref7","first-page":"679","article-title":"Population pharmacokinetics of albendazole in patients with neurocysticercosis","volume":"47","author":"Castro","year":"2009","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"S0031182020000670_ref31","volume-title":"Guide for the Care and use of Laboratory Animals","year":"2011"},{"key":"S0031182020000670_ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003950"},{"key":"S0031182020000670_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2015.06.030"},{"key":"S0031182020000670_ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600600902"},{"key":"S0031182020000670_ref15","first-page":"385","volume-title":"Handbook of Pharmaceutical Excipients","author":"Collett","year":"2000"},{"key":"S0031182020000670_ref41","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v14.i1.10"},{"key":"S0031182020000670_ref19","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198815020-00001"},{"key":"S0031182020000670_ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-006-0381-y"},{"key":"S0031182020000670_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(96)00640-7"},{"key":"S0031182020000670_ref22","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00231"},{"key":"S0031182020000670_ref24","doi-asserted-by":"publisher","DOI":"10.1021\/mp034006h"},{"key":"S0031182020000670_ref25","first-page":"259","volume-title":"Advances in Parasitology","volume":"96","author":"Kern","year":"2017"},{"key":"S0031182020000670_ref30","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1988.11812210"},{"key":"S0031182020000670_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2014.01.027"},{"key":"S0031182020000670_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2015.09.016"},{"key":"S0031182020000670_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2019.02.002"},{"key":"S0031182020000670_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2017.12.022"},{"key":"S0031182020000670_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.09.005"},{"key":"S0031182020000670_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.09.007"},{"key":"S0031182020000670_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.10.034"},{"key":"S0031182020000670_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2009.07.006"},{"key":"S0031182020000670_ref3","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016212804288"},{"key":"S0031182020000670_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(02)00096-7"}],"container-title":["Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0031182020000670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T12:47:29Z","timestamp":1593694049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0031182020000670\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0031182020000670"],"URL":"https:\/\/doi.org\/10.1017\/s0031182020000670","relation":{},"ISSN":["0031-1820","1469-8161"],"issn-type":[{"value":"0031-1820","type":"print"},{"value":"1469-8161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"Copyright \u00a9 The Author(s) 2020. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}